RPRX Royalty Pharma Plc

$36.32

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 10/2/2025

About Royalty Pharma Plc

Royalty Pharma plc is a buyer of biopharmaceutical royalties and funder of innovations in the biopharmaceutical industry in the United States. The company is headquartered in New York, New York.

Website: https://www.royaltypharma.com

Sector
LIFE SCIENCES
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1802768
Address
110 EAST 59TH STREET, NEW YORK, NY, US
Valuation
Market Cap
$18.72B
P/E Ratio
17.07
PEG Ratio
2.28
Price to Book
2.03
Performance
EPS
$1.91
Dividend Yield
2.70%
Profit Margin
38.00%
ROE
13.00%
Technicals
50D MA
$32.55
200D MA
$28.79
52W High
$34.20
52W Low
$23.89
Fundamentals
Shares Outstanding
433M
Target Price
$40.03
Beta
0.49

RPRX EPS Estimates vs Actual

● Estimated
● Actual

RPRX News & Sentiment

Sep 29, 2025 • GlobeNewswire SOMEWHAT-BULLISH
Royalty Pharma Appoints Dr. Ted W. Love As Lead Independent Director
NEW YORK, Sept. 29, 2025 ( GLOBE NEWSWIRE ) -- Royalty Pharma plc ( Nasdaq: RPRX ) today announced that the independent directors of the Board have unanimously appointed Dr. Ted W. Love, an independent director since 2020, as Lead Independent Director.
Sep 29, 2025 • Benzinga SOMEWHAT-BULLISH
Royalty Pharma Appoints Dr. Ted W. Love As Lead Independent Director - Royalty Pharma ( NASDAQ:RPRX )
NEW YORK, Sept. 29, 2025 ( GLOBE NEWSWIRE ) -- Royalty Pharma plc ( NASDAQ: RPRX ) today announced that the independent directors of the Board have unanimously appointed Dr. Ted W. Love, an independent director since 2020, as Lead Independent Director.
Sep 26, 2025 • Zacks Commentary NEUTRAL
Trump Slams 100% Tariff on Imported Drugs: Pharma ETFs Take a Hit
Trump's 100% tariff on imported drugs jolts markets, slamming pharma giants and dragging ETFs like XPH, FTXH, IHE, and PPH lower.
Sep 19, 2025 • GlobeNewswire SOMEWHAT-BULLISH
Royalty Pharma to Present at Bernstein's 2nd Annual Healthcare Forum
NEW YORK, Sept. 19, 2025 ( GLOBE NEWSWIRE ) -- Royalty Pharma plc ( Nasdaq: RPRX ) today announced that it will participate in a fireside chat at Bernstein's 2nd Annual Healthcare Forum on Tuesday, September 23, 2025 at 2:50 p.m. ET.
Sep 19, 2025 • Benzinga NEUTRAL
Royalty Pharma to Present at Bernstein's 2nd Annual Healthcare Forum - Royalty Pharma ( NASDAQ:RPRX )
NEW YORK, Sept. 19, 2025 ( GLOBE NEWSWIRE ) -- Royalty Pharma plc RPRX today announced that it will participate in a fireside chat at Bernstein's 2nd Annual Healthcare Forum on Tuesday, September 23, 2025 at 2:50 p.m. ET.
Sep 16, 2025 • Benzinga SOMEWHAT-BULLISH
How Do Investors Really Feel About Royalty Pharma? - Royalty Pharma ( NASDAQ:RPRX )
Royalty Pharma's RPRX short interest as a percent of float has risen 18.13% since its last report. According to exchange reported data, there are now 16.62 million shares sold short, which is 3.91% of all regular shares that are available for trading.
Sentiment Snapshot

Average Sentiment Score:

0.249
50 articles with scored sentiment

Overall Sentiment:

Bullish

RPRX Reported Earnings

Feb 13, 2025
Dec 31, 2024 (Pre market)
0.1 Surprise
  • Reported EPS: $1.15
  • Estimate: $1.05
  • Whisper: —
  • Surprise %: 9.2%
Nov 06, 2024
Sep 30, 2024 (Pre market)
0.08 Surprise
  • Reported EPS: $1.01
  • Estimate: $0.93
  • Whisper: —
  • Surprise %: 8.6%
Aug 08, 2024
Jun 30, 2024 (Pre market)
-0.01 Surprise
  • Reported EPS: $0.96
  • Estimate: $0.97
  • Whisper: —
  • Surprise %: -1.0%
May 09, 2024
Mar 31, 2024 (Pre market)
0.0 Surprise
  • Reported EPS: $0.98
  • Estimate: $0.98
  • Whisper: —
  • Surprise %: 0.0%
Feb 15, 2024
Dec 31, 2023 (Pre market)
0.14 Surprise
  • Reported EPS: $1.15
  • Estimate: $1.01
  • Whisper: —
  • Surprise %: 13.9%
Nov 08, 2023
Sep 30, 2023 (Pre market)
0.03 Surprise
  • Reported EPS: $0.79
  • Estimate: $0.76
  • Whisper: —
  • Surprise %: 4.0%
Aug 08, 2023
Jun 30, 2023 (Pre market)
0.03 Surprise
  • Reported EPS: $0.84
  • Estimate: $0.81
  • Whisper: —
  • Surprise %: 3.7%
May 09, 2023
Mar 31, 2023 (Pre market)
0.33 Surprise
  • Reported EPS: $1.60
  • Estimate: $1.27
  • Whisper: —
  • Surprise %: 26.0%
Feb 15, 2023
Dec 31, 2022 (Pre market)
0.09 Surprise
  • Reported EPS: $1.56
  • Estimate: $1.47
  • Whisper: —
  • Surprise %: 6.1%

Financials